企業プロフィール
Adicet Bio 株価・ニュース・カタリスト
- ティッカー:
- ACET
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
8.74 USD (+4.30%)
終値
最終更新: 2026年8月17日
75.8M USD
時価総額
株価変動の要因
As of Aug 17, 2026, ACET closed up 4.30% at $8.74. No new same-company headline was identified in the current news window.
企業概要
事業概要
Adicet Bio is a cell-therapy company focused on gamma delta T-cell therapies for cancer and immune disease. Its platform is trying to create off-the-shelf cell therapies with broader utility.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Adicet sits in advanced cell therapy.
ビジネスモデルの特徴
The business depends on platform validation, manufacturing execution, and early clinical proof-of-concept.
バイオ業界での位置付け
Adicet is a high-catalyst cell-therapy name whose valuation is highly sensitive to translational progress.
今後のカタリスト
- Adicet’s catalysts are ADI-001 and the rest of its allogeneic gamma delta CAR-T platform. The company needs clinical updates that keep the allogeneic story credible.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。